Sign Up to like & get
recommendations!
1
Published in 2022 at "Theranostics"
DOI: 10.7150/thno.56736
Abstract: Background: Antibodies targeting surface expressed disialoganglioside GD2 are increasingly used in neuroblastoma immunotherapy and might also have potential for use in radioimmunotherapy. As such targeted treatments might benefit from a dedicated theranostic approach, we studied…
read more here.
Keywords:
ch14 cho;
gd2;
translational immunopet;
antibody ... See more keywords